195 related articles for article (PubMed ID: 3404163)
1. Effect of bromocriptine and metoclopramide on serum prolactin levels in patients with amyotrophic lateral sclerosis.
Szulc-Kuberska J; Stepień H; Klimek A; Cieślak D
J Neurol Neurosurg Psychiatry; 1988 May; 51(5):643-5. PubMed ID: 3404163
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
3. Prolactin secretion in myotonic dystrophy.
Marinković Z; Prelevic G; Han R; Würzburger M; Todorovic S
Exp Clin Endocrinol; 1990 Dec; 96(3):247-52. PubMed ID: 2128051
[TBL] [Abstract][Full Text] [Related]
4. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
5. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
Baranowska B; Jeske W; Szymanowski J; Piechna K
J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
[TBL] [Abstract][Full Text] [Related]
6. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach.
Sowers J; Catania R; Paris J; Tuck M
J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482
[TBL] [Abstract][Full Text] [Related]
7. Effects of metoclopramide and bromocriptine on prolactin secretion in the pregnant ewe.
Fitzgerald BP; Cunningham FJ
J Endocrinol; 1982 Apr; 93(1):41-6. PubMed ID: 7069345
[TBL] [Abstract][Full Text] [Related]
8. Is normoreninemic essential hypertension caused by disordered central dopaminergic regulation?
Ogihara T; Maruyama A; Naka T; Higaki J; Kanda T; Goto M; Onishi T; Kumahara Y
Clin Exp Hypertens (1978); 1980; 2(1):89-97. PubMed ID: 6774864
[TBL] [Abstract][Full Text] [Related]
9. [Effect of bromocriptine on prolactin secretion after dopaminergic receptor blockade with metoclopramide in patients with prostatic cancer treated with estrogens].
Baranowska B; Szymanowski J; Jeske W
Endokrynol Pol; 1984; 35(4):211-7. PubMed ID: 6510364
[No Abstract] [Full Text] [Related]
10. [Effect of metoclopramide on prolactin secretion in amyotrophic lateral sclerosis].
Szulc-Kuberska J; Stepień H; Klimek A; Cieślak D
Pol Tyg Lek; 1987 Nov; 42(45):1419-20. PubMed ID: 3447105
[No Abstract] [Full Text] [Related]
11. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
Kubota T; Yaoi Y; Nagae M; Kumasaka T; Saito M
Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
[TBL] [Abstract][Full Text] [Related]
12. [Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
Díaz F; Liberman C; Chariá P
Rev Med Chil; 1991 Mar; 119(3):252-7. PubMed ID: 1842116
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.
Mekki QA; Turner P
Br J Ophthalmol; 1985 Dec; 69(12):909-10. PubMed ID: 4084483
[TBL] [Abstract][Full Text] [Related]
15. Reductions in plasma prolactin during acute erythropoietin administration.
Markianos M; Kosmidis ML; Sfagos C
Neuro Endocrinol Lett; 2006 Jun; 27(3):355-8. PubMed ID: 16816832
[TBL] [Abstract][Full Text] [Related]
16. Prolactin stimulation in multiple sclerosis--an indicator of disease subtypes and activity?
Heesen C; Gold SM; Bruhn M; Mönch A; Schulz KH
Endocr Res; 2002; 28(1-2):9-18. PubMed ID: 12108793
[TBL] [Abstract][Full Text] [Related]
17. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
[TBL] [Abstract][Full Text] [Related]
18. [Dopaminergic regulation of the hypothalamo-hypophyseal system in patients with hypophyseal adenomas].
Balabolkin MI; Gerasimov GA; Snigireva RIa; Pisarskaia IV; Liubimov AV
Probl Endokrinol (Mosk); 1989; 35(5):3-6. PubMed ID: 2587520
[TBL] [Abstract][Full Text] [Related]
19. [Effect of dopaminergic agents on the endocrine profile in labor and early puerperium].
Kubota T; Nagae M; Kamata S; Oohara M; Saito M; Kumasaka T; Yaoi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):945-54. PubMed ID: 4020203
[TBL] [Abstract][Full Text] [Related]
20. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
Bohnet HG; Kato K; De Moll H
Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
